On CNBC’s ‘Halftime Report Final Trades,’ a panel of financial experts shared their top stock picks, offering insights into the market and potential investment opportunities.
Stephen L. Weiss of Short Hills Capital Partners recommended buying TransDigm Group Incorporated (TDG). TransDigm Group recently reported better-than-expected third-quarter financial results and raised its FY24 guidance, suggesting positive future prospects.
Jason Snipe of Odyssey Capital Advisors highlighted BJ’s Wholesale Club Holdings, Inc. (BJ) as a strong pick. BJ’s Wholesale reported strong second-quarter financial results, exceeding analysts’ expectations. The company saw a revenue growth of 4.9% year-over-year, reaching $5.205 billion, surpassing the estimated $5.145 billion. Comparable club sales also showed a positive trend, increasing by 3.1% overall and 2.4% excluding gasoline sales.
Anastasia Amoroso of iCapital suggested adding to the VanEck Semiconductor ETF (SMH). The semiconductor space has experienced a downturn, with a 17% decline, making it an attractive entry point for investors seeking potential growth opportunities.
Joe Terranova of Virtus Investment Partners chose AbbVie Inc. (ABBV) as his final trade. AbbVie’s CONSTELLA, a treatment for childhood constipation, received Health Canada approval. This approval signifies a potential market expansion for AbbVie, as childhood constipation is a common issue that can significantly impact children’s quality of life and cause stress for families.
In terms of price action, TransDigm closed at $1,372.92 on Monday, gaining 0.4%. BJ’s Wholesale shares fell by 1.1% to settle at $80.57. The VanEck Semiconductor ETF declined by 1.3% during the day’s trading session. AbbVie shares closed at $195.73, showing a 0.8% gain.
These expert insights provide valuable information for investors considering adding these companies to their portfolios. Each pick represents a potential investment opportunity with unique growth drivers and market potential.
